Abstract

This review explores the intricate dynamics of hematocrit fluctuations in individuals experiencing concurrent HIV and malaria infections, highlighting the challenges and clinical implications of these hematological changes. Hematocrit levels, a critical indicator of red blood cell mass, are significantly influenced by the synergistic interaction of these two prevalent diseases, leading to diagnostic complexities and impacting therapeutic strategies. The review delves into the underlying mechanisms behind hematocrit alterations in HIV-malaria coinfection, emphasizing the importance of understanding these fluctuations for improved diagnostic accuracy and tailored therapeutic interventions. Diagnostic challenges arising from the overlapping hematological changes in coinfection are discussed, along with the clinical implications, emphasizing the need for a nuanced approach to management. By synthesizing existing literature, this article provides valuable insights into the complex interplay of HIV and malaria on hematocrit levels, offering a foundation for clinicians, researchers, and public health practitioners to enhance the management of individuals facing this dual burden.